Iovance Biotherapeutics, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Iovance Biotherapeutics, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Iovance Biotherapeutics, Inc. stocks after a simple registration process. </div>

Q: How to buy Iovance Biotherapeutics, Inc. shares in India?

<div> To buy Iovance Biotherapeutics, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Iovance Biotherapeutics, Inc. and you are done!</div> </div>

Q: What is the share price of Iovance Biotherapeutics, Inc.?

<div>The share price of Iovance Biotherapeutics, Inc. is USD 12.88 as on 2 May.</div>

Q: What is the Market Capitalization of Iovance Biotherapeutics, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Iovance Biotherapeutics, Inc. is USD 3.6B as on 2 May.</div>

Q: What is the PE ratio of Iovance Biotherapeutics, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Iovance Biotherapeutics, Inc. is N/A as on 2 May. </div>

Q: Is Iovance Biotherapeutics, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Iovance Biotherapeutics, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Iovance Biotherapeutics, Inc. operate?

<div> Iovance Biotherapeutics, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$12.88

+0.38

(2 May)

Loading Chart

Previous close

$12.88

Open

$12.88

Today’s high

$12.90

Today’s low

$12.31

52W low

$3.21

52W high

$18.33

109.69%

3.39%

Shares O/S

279.83M

Market cap

3.6B

Insights

IOVA price is below its 200 day moving average

IOVA is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.

In beta. Send feedback here.

Compare with other stock

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops and delivers tumor infiltrating lymphocyte (TIL), therapies for patients with solid tumor cancers. Its lead product candidate, Amtagvi (lifileucel), is a tumor-derived autologous T cell immunotherapy indicated for the treatment of adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor.

The Company also marketing Proleukin (aldesleukin), aninterleukin-2, or IL-2, product used in the Amtagvi treatment regimen. Its development pipeline includes multicenter trials of TIL cell therapies in additional treatment settings for solid tumor cancers. Amtagvi and Proleukin are part of a treatment regimen that also includes lymphodepletion. The Company is also developing next generation therapies using TIL, such as genetically modified TIL cell therapy. .

FAQs

Can I buy Iovance Biotherapeutics, Inc. shares in India?

How to buy Iovance Biotherapeutics, Inc. shares in India?

What is the share price of Iovance Biotherapeutics, Inc.?

What is the Market Capitalization of Iovance Biotherapeutics, Inc.?

What is the PE ratio of Iovance Biotherapeutics, Inc.?

Is Iovance Biotherapeutics, Inc. a good stock to buy?

In which sector / industry does Iovance Biotherapeutics, Inc. operate?